Using nanoparticles to enhance the healing of knee meniscus injuries
Activation of endogenous progenitors via a nanoparticle-conjugated fibrous system to enhance meniscus repair
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-11012350
This study is looking at a new way to help heal knee injuries by using special particles to activate cells in the meniscus, which could lead to better recovery and less chance of developing arthritis, making it a promising option for people with meniscus damage.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11012350 on ClinicalTrials.gov |
What this research studies
This research investigates how activating specific progenitor cells in the knee meniscus can improve healing after injuries. By using a nanoparticle-conjugated system, the study aims to deliver signals that stimulate these cells to repair damaged meniscus tissue more effectively. The approach involves both laboratory experiments and animal models to understand the mechanisms of repair and the potential for clinical application in humans. Patients may benefit from new treatments that restore knee function and reduce the risk of osteoarthritis following meniscus injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with knee meniscus injuries, particularly those who are experiencing limited healing or function.
Not a fit: Patients with chronic knee conditions unrelated to meniscus injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that significantly improve recovery from knee meniscus injuries.
How similar studies have performed: Previous research has shown promising results in using similar approaches to enhance tissue repair, indicating potential for success in this novel application.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: QIN, LING — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: QIN, LING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.